In addition, we measured AAT plasma concentrations in order to investigate if the ratios between NSPs and their natural inhibitor were altered in NAFLD and type 2 diabetes when compared to healthy controls. Here, SERPINA1 is linked to metabolic dysfunction-associated steatotic liver disease.